国: イギリス
言語: 英語
ソース: MHRA (Medicines & Healthcare Products Regulatory Agency)
Propylthiouracil
RPH Pharmaceuticals AB
H03BA02
Propylthiouracil
50mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 06020200; GTIN: 5060064791318 5060064791301
PATIENT INFORMATION LEAFLET: PROPYLTHIOURACIL TABLETS BP 50 MG (PROPYLTHIOURACIL) Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. PET004675-UK WHAT IS IN THIS LEAFLET: 1. What Propylthiouracil Tablets are and what they are used for 2. What you need to know before you take Propylthiouracil Tablets 3. How to take Propylthiouracil Tablets 4. Possible side effects 5. How to store Propylthiouracil Tablets 6. Contents of the pack and other information. 1. WHAT PROPYLTHIOURACIL TABLETS ARE AND WHA The active ingredient in Propylthiouracil Tablets is Propylthiouracil. Propylthiouracil Tablets are used in the treatment of hyperthyroidism. Hyperthyroidism is where an overactive thyroid gland produces too much thyroid hormone. They are also used to treat Graves’ disease, thyrotoxicosis and thyrotoxic crisis (when levels of thyroid hormone are dangerously high). Propylthiouracil Tablets may also be giv en to lower very high levels of thyroid hormone before surgery or radioactive iodine treatment. Children may be given Propylthiouracil Tablets to delay the need for surgery (or other treatment to remove part of an overactive thyroid gland). 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE PROPYLTHIOURACIL TABLETS DO NOT TAKE PROPYLTHIOURACIL TABLETS IF YOU: • Think you may be allergic to Propylthiouracil or to any of the other ingredients of Propylthiouracil Tablets. (These are listed in section 6.); TALK TO YOUR DOCTOR OR PHARMACIST BEFORE TAKING WARNINGS AND PRECAUTIONS PROPYLTHIOURACIL TABLETS IF YOU: • Have ever had an adverse rea 完全なドキュメントを読む
OBJECT 1 PROPYLTHIOURACIL TABLETS BP 50MG Summary of Product Characteristics Updated 08-Dec-2022 | RPH Pharmaceuticals AB • 1. Name of the medicinal product • 2. Qualitative and quantitative composition • 3. Pharmaceutical form • 4. Clinical particulars • 4.1 Therapeutic indications • 4.2 Posology and method of administration • 4.3 Contraindications • 4.4 Special warnings and precautions for use • 4.5 Interaction with other medicinal products and other forms of interaction • 4.6 Fertility, pregnancy and lactation • 4.7 Effects on ability to drive and use machines • 4.8 Undesirable effects • 4.9 Overdose • 5. Pharmacological properties • 5.1 Pharmacodynamic properties • 5.2 Pharmacokinetic properties • 5.3 Preclinical safety data • 6. Pharmaceutical particulars • 6.1 List of excipients • 6.2 Incompatibilities • 6.3 Shelf life • 6.4 Special precautions for storage • 6.5 Nature and contents of container • 6.6 Special precautions for disposal and other handling • 7. Marketing authorisation holder • 8. Marketing authorisation number(s) • 9. Date of first authorisation/renewal of the authorisation • 10. Date of revision of the text 1. Name of the medicinal product Propylthiouracil Tablets BP 50mg 2. Qualitative and quantitative composition Propylthiouracil 50mg Excipient with known effect: Lactose 25mg per tablet For the full list of excipients, see section 6.1. 3. Pharmaceutical form White biconvex uncoated tablets engraved Evans 184 on one face and plain on the other. 4. Clinical particulars 4.1 Therapeutic indications 1. Management of hyperthyroidism, including the treatment of Graves' disease and thyrotoxicosis. 2. Amelioration of hyperthyroidism in preparation for surgical treatment. 3. An adjunct to radioactive iodine therapy. 4. In juvenile hyperthyroidism to delay ablative therapy. 5. To manage thyrotoxic crisis. 4.2 Posology and method of administration Propylthiouracil is administered by the oral route. Adults: Management of Hyperthyroidism The initial d 完全なドキュメントを読む